- Home
- EQ vs TRBG Comparison
EQ vs TRBG Comparison
Compare EQ & TRBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EQ | TRBG |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | Israel |
| Employees | N/A | 20 |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.4M | 81.6M |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | EQ | TRBG |
|---|---|---|
| Price | $1.52 | $3.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $8.56 | N/A |
| AVG Volume (30 Days) | ★ 344.2K | 21.3K |
| Earning Date | 11-20-2026 | 09-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,095,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.16 | $2.98 |
| 52 Week High | $6.20 | $5.84 |
Technical Indicators
Market Signals| Indicator | EQ | TRBG |
|---|---|---|
| Relative Strength Index (RSI) | 53.88 | 55.94 |
| Support Level | $1.30 | $3.50 |
| Resistance Level | $2.53 | $4.15 |
| Average True Range (ATR) | 0.13 | 0.32 |
| MACD | 0.04 | 0.06 |
| Stochastic Oscillator | 79.55 | 83.75 |
Price Performance
Historical ComparisonAbout EQ Equillium Inc.
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.
About TRBG TurboGen Ltd. Ordinary Shares
Turbogen Ltd is engaged in developing multifuel CHP systems with a vision of providing on-site energy for buildings. Its CHP systems outperform current electric efficiency solutions, enabling fast ROI, lower building emissions, and peak saving for utilities. The company's multi-fuel technology enables hybrid Operations: Solar-Gas, Hydrogen-Gas, SOFC-Gas.